Autoimmune lymphoproliferative syndrome - Impaired regulation of the immune response by impaired induction of apoptosis

3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Autoimmune lymphoproliferative syndrome (ALPS) is an inherited disease hindering apoptosis of lymphocytes. It includes mutations in genes coding for various components of the apoptotic pathway: CD95 (ALPS 0 and ALPS la), CD178 (ALPS Ib) and caspase-10 (ALPS II). Moreover, patients with genetically inherited caspase-8 or other components of apoptosis-inducing pathway deficiencies (ALPS III) have been described recently. In addition, ALPS-like clinical patterns, including Dianzani's autoimmune lymphoproliferative disease (DALD), were characterized. In this review, we summarize currently known types of ALPS and characterize their immunological and molecular background. © 2006 S. Karger GmbH.

Cite

CITATION STYLE

APA

Brawura-Biskupski-Samaha, R., & Grzela, T. (2006, January). Autoimmune lymphoproliferative syndrome - Impaired regulation of the immune response by impaired induction of apoptosis. Transfusion Medicine and Hemotherapy. https://doi.org/10.1159/000090202

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free